Heterogeneity of computational pathomic signature predicts drug resistance and intra-tumor heterogeneity of ovarian cancer

Qiuli Zhu(Nanchang University), Chao Shi(Nanchang University), Weiming Lou(Nanchang University), Feng Qiu(Nanchang University), Hua Dai(Nanchang University), Xin Wang(Jiangsu University), Libin Deng(Nanchang University)

Translational Oncology

January 6, 2024

10.1016/j.tranon.2023.101855

Cited by 16

Related Papers

The consensus molecular subtypes of colorectal cancer

|Nature Medicine|2015|5.3k

Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders

|Proceedings of the National Academy of Sciences|2010|854

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome

|Science|2002|370

Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas

|Gastroenterology|2019|225